Orbimed Advisors Llc sold $900K of PMV Pharmaceuticals (PMVP)

Executed Sep 10 2025, disclosed Sep 12 2025, 2 days later.

Value, as filed

$900K

500,000 sh × $1.80

Executed

Sep 10 2025

the trade date, as filed

Disclosed

Sep 12 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

OL Orbimed Advisors Llc Director profile →

Orbimed Advisors Llc (Director) filed 15 Form 4 reports as a reporting entity in the trailing twelve months (7 purchases, 8 sales, 1 filed past the two-business-day deadline), most often in Sionna Therapeutics, Inc. (SION). Across 7 priced purchase filings, the average 21-session return was +16.9% from execution and +18.9% from disclosure (delay-adjusted; derived). The largest single filing was $38.9M of ELVN (858,646 sh across 3 lots, as filed), executed Jun 22.

The name

PMVP PMVP PMVP · 2 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→